November 14, 2023- Premier, Inc. announced it has joined the End Drug Shortages Alliance, a coalition of diverse stakeholders to address drug shortages in the United States. The Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare’s more pressing and enduring issues: drug shortages that disrupt patient care.
The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply.
For more than two decades, Premier and its members have been leaders in preventing and resolving drug shortages. Through commitment and aggregated demand, Premier’s drug shortage programs give manufacturers proper demand signaling, predictable revenue and the surety needed to ramp up and maintain production. As a result of Premier’s innovations, the company has successfully contributed to the resolution of 15 drug shortages, resulting in their removal from the FDA shortage list.